Rockefeller Capital Management L.P. Fulgent Genetics, Inc. Transaction History

Rockefeller Capital Management L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Mar 06, 2023	SELL	$29.23 - $40.28 $1,578 - $2,175	-54 Reduced 2.51%	2,094 $62,000
Q3 2022 Nov 02, 2022	BUY	$37.92 - $63.74 $74,778 - $125,695	1,972 Added 1120.45%	2,148 $81,000
Q2 2022 Aug 12, 2022	SELL	$47.98 - $62.75 $7,676 - $10,040	-160 Reduced 47.62%	176 $9,000
Q1 2022 May 13, 2022	SELL	$49.85 - $96.11 $47,108 - $90,823	-945 Reduced 73.77%	336 $20,000
Q4 2021 Feb 14, 2022	BUY	$77.3 - $105.0 $1,391 - $1,890	18 Added 1.43%	1,281 $128,000
Q3 2021 Nov 12, 2021	BUY	$74.87 - $110.87 $5,315 - $7,871	71 Added 5.96%	1,263 $113,000
Q2 2021 Aug 10, 2021	SELL	$66.8 - $100.45 $883,430 - $1.33 Million	-13,225 Reduced 91.73%	1,192 $109,000
Q1 2021 May 11, 2021	BUY	$59.3 - $183.85 $4,862 - $15,075	82 Added 0.57%	14,417 $1.39 Million
Q4 2020 Feb 12, 2021	BUY	$31.01 - $52.1 $444,528 - $746,853	14,335 New	14,335 $746,000

200

16M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $513M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.